| Latest on CP Wire |
|---|
| SIFI reports positive results from 044/si phase 3 clinical trial further highlighting strength of its NETILDEX® franchise |
| Tue, 08/25/20 - 01:22 pm |
| Highlights: 2020 Cardiometabolic Health Congress West Live Online |
| Fri, 08/21/20 - 12:25 am |
| Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections |
| Mon, 08/3/20 - 09:59 am |
| How Contingency Fee Arrangements Empower Whistleblowers |
| Wed, 06/24/20 - 10:42 am |
| COVID-19 Employment and Whistleblower Issues - Interview With an Employment Attorney |
| Wed, 06/3/20 - 11:01 am |
| Active Symptom Monitoring Won’t be Effective in Controlling Spread of COVID-19 Once World Returns to “New Normal,” Study Suggests |
| Tue, 06/2/20 - 04:48 pm |
| Cybersecurity, Pharma, and Whistleblowing |
| Fri, 05/15/20 - 03:56 pm |
| What does federal Coronavirus legislation mean for pharmaceutical employees – and whistleblowers? |
| Wed, 04/15/20 - 10:34 pm |
| Combating Nursing Home Fraud Results in Millions Being Paid to the Government and Whistleblowers |
| Tue, 04/7/20 - 10:26 am |
| Signs Of Fraud In The Health Sector [sponsored] |
| Mon, 04/6/20 - 09:58 pm |
|
| rssfeedwidget.com |